Literature DB >> 24469719

Identification of novel significant variants of ZFPM2/FOG2 in non-syndromic Tetralogy of Fallot and double outlet right ventricle in a Chinese Han population.

Xiaomin Huang1, Wenquan Niu, Zhen Zhang, Chunxia Zhou, Zhiwei Xu, Jinfen Liu, Zhaokang Su, Wenxiang Ding, Haibo Zhang.   

Abstract

Tetralogy of Fallot (TOF) and double outlet right ventricle (DORV) are two common subtypes of conotruncal defects. Recent reports have implicated mutations in the zinc finger protein, FOG family member 2 (ZFPM2/FOG2) as a cause of TOF/DORV, but no current literature focuses on the relationship between ZFPM2/FOG2 gene and non-syndromic TOF and DORV in Chinese Han population. The purpose of this study was to estimate the occurrence and the prevalence of ZFPM2/FOG2 genetic variants in Chinese Han population with non-syndromic TOF and DORV and to investigate genotype-phenotype correlations in individuals with ZFPM2/FOG2 mutations. The whole exons of ZFPM2/FOG2 were sequenced in 98 non-syndromic TOF/DORV patients and 200 control subjects. All the six variants (G2482A, G1552A, A2107C, C452T, C3239T, C1208G) changed the amino acid (p.Val828Met, p.Ala518Thr, p.Met703Leu, p.Thr151Ile, p.Ser1080Phe, p.Ala403Gly), in which four variants (G2482A, C452T, G1552A, C3239T) were not reported before and absent in control subjects. Further analysis revealed that only occurrences of variants G2482A and A2107C had statistical significance compared to the control group (P < 0.05). In conclusion, our results provide strong evidence regarding the susceptibility of the ZFPM2 gene to the development of non-syndromic TOF/DORV. It suggests that ZFPM2/FOG2 genetic variants may be a novel potential bio-markers and treatment targets for the non-syndromic TOF and DORV.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24469719     DOI: 10.1007/s11033-014-3126-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

1.  Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart.

Authors:  Fiona A Stennard; Mauro W Costa; David A Elliott; Scott Rankin; Saskia J P Haast; Donna Lai; Lachlan P A McDonald; Karen Niederreither; Pascal Dolle; Benoit G Bruneau; Aaron M Zorn; Richard P Harvey
Journal:  Dev Biol       Date:  2003-10-15       Impact factor: 3.582

Review 2.  Regulation of GATA4 transcriptional activity in cardiovascular development and disease.

Authors:  Pingzhu Zhou; Aibin He; William T Pu
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

Review 3.  Genetic and environmental influences on malformations of the cardiac outflow tract.

Authors:  Karen S Kuehl; Christopher A Loffredo
Journal:  Expert Rev Cardiovasc Ther       Date:  2005-11

4.  Morphogenesis of bulboventricular malformations. II. Observations on malformed hearts.

Authors:  R H Anderson; J L Wilkinson; R Arnold; A E Becker; K Lubkiewicz
Journal:  Br Heart J       Date:  1974-10

5.  Novel ZFPM2/FOG2 variants in patients with double outlet right ventricle.

Authors:  Z-P Tan; C Huang; Z-B Xu; J-F Yang; Y-F Yang
Journal:  Clin Genet       Date:  2011-10-30       Impact factor: 4.438

Review 6.  The epidemiology and genetics of congenital heart disease.

Authors:  E Goldmuntz
Journal:  Clin Perinatol       Date:  2001-03       Impact factor: 3.430

7.  FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium.

Authors:  S G Tevosian; A E Deconinck; M Tanaka; M Schinke; S H Litovsky; S Izumo; Y Fujiwara; S H Orkin
Journal:  Cell       Date:  2000-06-23       Impact factor: 41.582

8.  New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot and double outlet right ventricle.

Authors:  Alessandro De Luca; A Sarkozy; R Ferese; F Consoli; F Lepri; M L Dentici; P Vergara; A De Zorzi; P Versacci; M C Digilio; B Marino; B Dallapiccola
Journal:  Clin Genet       Date:  2010-08-02       Impact factor: 4.438

9.  Molecular cloning of FOG-2: a modulator of transcription factor GATA-4 in cardiomyocytes.

Authors:  E C Svensson; R L Tufts; C E Polk; J M Leiden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

10.  Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants.

Authors:  Helen R Griffin; Ana Töpf; Elise Glen; Christiane Zweier; A Graham Stuart; Jonathan Parsons; Ian Peart; John Deanfield; John O'Sullivan; Anita Rauch; Peter Scambler; John Burn; Heather J Cordell; Bernard Keavney; Judith A Goodship
Journal:  Heart       Date:  2010-10       Impact factor: 5.994

View more
  5 in total

1.  CpG island shore methylation of ZFPM2 is identified in tetralogy of fallot samples.

Authors:  Wei Sheng; Long Chen; Huijun Wang; Xiaojing Ma; Duan Ma; Guoying Huang
Journal:  Pediatr Res       Date:  2016-03-09       Impact factor: 3.756

2.  Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations.

Authors:  Jonathan H Chung; Jinlu Cai; Barrie G Suskin; Zhengdong Zhang; Karlene Coleman; Bernice E Morrow
Journal:  Hum Mutat       Date:  2015-07-02       Impact factor: 4.878

3.  Identification of ZFPM2 mutations in sporadic conotruncal heart defect patients.

Authors:  Tian Pu; Yang Liu; Rang Xu; Fen Li; Sun Chen; Kun Sun
Journal:  Mol Genet Genomics       Date:  2017-10-10       Impact factor: 3.291

4.  Novel missense variants of ZFPM2/FOG2 identified in conotruncal heart defect patients do not impair interaction with GATA4.

Authors:  Wenwen Zhang; Li Shen; Zhantao Deng; Yibing Ding; Xuming Mo; Zhengfeng Xu; Qian Gao; Long Yi
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

5.  Exome sequencing identifies rare variants in multiple genes in atrioventricular septal defect.

Authors:  Lisa C A D'Alessandro; Saeed Al Turki; Ashok Kumar Manickaraj; Dorin Manase; Barbara J M Mulder; Lynn Bergin; Herschel C Rosenberg; Tapas Mondal; Elaine Gordon; Jane Lougheed; John Smythe; Koen Devriendt; Shoumo Bhattacharya; Hugh Watkins; Jamie Bentham; Sarah Bowdin; Matthew E Hurles; Seema Mital
Journal:  Genet Med       Date:  2015-05-21       Impact factor: 8.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.